Merck & Co., Inc. (MRK) 재무상태표
NYSE · Healthcare · Drug Manufacturers - General · 직원 74,000명 · CEO Robert Davis
- 주가
- $149.52 +2.18%
- 시가총액
- $3690억
- 기업가치
- $4160억
- 최근 실적
- Q3 '26 2026-09-30 제출
- 다음 실적
- 2027-02-02 EPS 추정 $1.79
Merck & Co., Inc. (MRK)의 Q2 '26말 현금 및 단기투자는 $71.4억, 리스 포함 차입금은 $539억입니다. 자산총계 $1300억, 부채총계 $878억, 주주지분 $419억.
재무상태표
| 재무상태표 | 추세 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $86.1억 | $68.4억 | $55.8억 | $113억 | $146억 | $132억 | $86.3억 | $80.1억 | $182억 | $146억 | $53.3억 | $68.5억 | |
| 단기투자 | $1.68억 | $2.52억 | $4000만 | $5000만 | $0 | $4.47억 | $5.99억 | $6.15억 | $4500만 | $0 | $3.75억 | $2.92억 | |
| 매출채권 | $104억 | $103억 | $114억 | $116억 | $114억 | $103억 | $108억 | $118억 | $121억 | $127억 | $122억 | $126억 | |
| 재고자산 | $61.3억 | $63.6억 | $65.1억 | $64.7억 | $62.4억 | $61.1억 | $62억 | $66억 | $64.4억 | $66.6억 | $64.8억 | $62.1억 | |
| 기타 유동자산 | $66.6억 | $83.7억 | $79.5억 | $87.4억 | $81.4억 | $87.1억 | $92.9억 | $100억 | $108억 | $94.9억 | $106억 | $108억 | |
| 유동자산 | $320억 | $322억 | $314억 | $382억 | $404억 | $388억 | $355억 | $371억 | $476억 | $435억 | $350억 | $367억 | |
| 유형자산(순액) | $225억 | $231억 | $230억 | $232억 | $234억 | $238억 | $248억 | $252억 | $256억 | $268억 | $254억 | $257억 | |
| 장기투자 | $13.1억 | $2.52억 | $2.8억 | $3.57억 | $5.75억 | $4.63억 | $6.16억 | $7.74억 | $11.2억 | $22.4억 | $11.1억 | $12.2억 | |
| 영업권 | $212억 | $212억 | $212억 | $212억 | $217억 | $217억 | $217억 | $216억 | $216억 | $216억 | $216억 | $216억 | |
| 무형자산 | $192억 | $180억 | $176억 | $170억 | $170억 | $164억 | $158억 | $152억 | $153억 | $267억 | $257억 | $250억 | |
| 기타 비유동자산 | $106억 | $120억 | $123억 | $127억 | $144억 | $160억 | $168억 | $177억 | $183억 | $160억 | $198억 | $196억 | |
| 비유동자산 | $748억 | $745억 | $744억 | $744억 | $772억 | $783억 | $796억 | $805억 | $820억 | $934억 | $937억 | $931억 | |
| 자산총계 | $1070억 | $1070억 | $1060억 | $1130억 | $1180억 | $1170억 | $1150억 | $1180억 | $1300억 | $1370억 | $1290억 | $1300억 | |
| 부채 | |||||||||||||
| 매입채무 | $35.1억 | $39.2억 | $35.1억 | $35.2억 | $35.9억 | $40.8억 | $37.8억 | $38.9억 | $41.5억 | $44억 | $38.6억 | $38.3억 | |
| 미지급비용 | $148억 | $158억 | $141억 | $147억 | $165억 | $157억 | $128억 | $145억 | $162억 | $8500만 | $145억 | $0 | |
| 단기차입금 | $8.87억 | $13.7억 | $30.8억 | $30.7억 | $31.5억 | $26.5억 | $13.6억 | $14.3억 | $14.1억 | $28.8억 | $24.4억 | $28.3억 | |
| 미지급세금 | $19.8억 | $26.5억 | $24억 | $27.8억 | $43.3억 | $39.1억 | $51.8억 | $41.6억 | $48.5억 | $0 | $39.5억 | $42.2억 | |
| 기타 유동부채 | $0 | -$2.85억 | $0 | $0 | $0 | -$2.82억 | $0 | $0 | $0 | $141억 | $0 | $189억 | |
| 유동부채 | $231억 | $257억 | $251억 | $261억 | $296억 | $284억 | $252억 | $260억 | $286억 | $283억 | $269억 | $277억 | |
| 장기차입금 | $340억 | $337억 | $311억 | $347억 | $350억 | $345억 | $335억 | $340억 | $400억 | $468억 | $467억 | $511억 | |
| 리스부채(비유동) | $0 | $9.28억 | $0 | $0 | $0 | $8.77억 | $0 | $0 | $0 | $9.01억 | $0 | $0 | |
| 이연법인세부채 | $10.2억 | $8.71억 | $9.22억 | $8.76억 | $8.64억 | $13.9억 | $14.1억 | $14.3억 | $13.8억 | $14.4억 | $14.9억 | $14.3억 | |
| 기타 비유동부채 | $73.4억 | $78.6억 | $82.6억 | $73.3억 | $75.4억 | $55.9억 | $66.6억 | $70.3억 | $76.6억 | $67.9억 | $76.4억 | $75.7억 | |
| 비유동부채 | $423억 | $433억 | $403억 | $429억 | $434억 | $423억 | $415억 | $424억 | $490억 | $559억 | $558억 | $601억 | |
| 부채총계 | $654억 | $690억 | $654억 | $690억 | $730억 | $707억 | $667억 | $685억 | $776억 | $842억 | $828억 | $878억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | |
| 이익잉여금 | $571억 | $539억 | $567억 | $602억 | $614억 | $631억 | $661억 | $685억 | $722억 | $731억 | $667억 | $633억 | |
| 기타포괄손익누계액 | -$49.2억 | -$51.6억 | -$52.7억 | -$53.6억 | -$53.7억 | -$49.5억 | -$49.7억 | -$54.2억 | -$52억 | -$42.9억 | -$40.6억 | -$39.4억 | |
| 주주지분 | $412억 | $376억 | $404억 | $436억 | $445억 | $463억 | $483억 | $490억 | $519억 | $526억 | $459억 | $419억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $349억 | $363억 | $342억 | $378억 | $381억 | $383억 | $348억 | $354억 | $414억 | $505억 | $491억 | $539억 | |
| 순차입금(차입금 - 현금) | $263억 | $294억 | $286억 | $265억 | $235억 | $250억 | $262억 | $274억 | $232억 | $360억 | $438억 | $471억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $65.2억 | $60.9억 | $79.7억 | $96.8억 | $80.5억 | $81억 | $127억 | $68.4억 | $132억 | $146억 | |
| 단기투자 | $78.3억 | $24.1억 | $8.99억 | $7.74억 | $0 | $0 | $4.98억 | $2.52억 | $4.47억 | $0 | |
| 매출채권 | $70.2억 | $68.7억 | $70.7억 | $67.8억 | $68억 | $92.3억 | $94.5억 | $103억 | $103억 | $127억 | |
| 재고자산 | $48.7억 | $51억 | $54.4억 | $59.8억 | $55.5억 | $59.5억 | $59.1억 | $63.6억 | $61.1억 | $66.6억 | |
| 기타 유동자산 | $43.9억 | $43억 | $45억 | $42.8억 | $73.6억 | $69.9억 | $71.7억 | $83.7억 | $87.1억 | $94.9억 | |
| 유동자산 | $306억 | $248억 | $259억 | $275억 | $278억 | $303억 | $357억 | $322억 | $388억 | $435억 | |
| 유형자산(순액) | $120억 | $124억 | $133억 | $151억 | $170억 | $193억 | $214억 | $231억 | $238억 | $268억 | |
| 장기투자 | $114억 | $121억 | $62.3억 | $14.7억 | $7.85억 | $3.7억 | $10.2억 | $2.52억 | $4.63억 | $22.4억 | |
| 영업권 | $182억 | $183억 | $183억 | $194억 | $189억 | $213억 | $212억 | $212억 | $217억 | $216억 | |
| 무형자산 | $173억 | $142억 | $131억 | $142억 | $141억 | $229억 | $203억 | $180억 | $164억 | $267억 | |
| 기타 비유동자산 | $58.5억 | $60.8억 | $58.8억 | $67.7억 | $131억 | $116억 | $95.3억 | $120억 | $160억 | $160억 | |
| 비유동자산 | $648억 | $631억 | $568억 | $569억 | $638억 | $754억 | $734억 | $745억 | $783억 | $934억 | |
| 자산총계 | $954억 | $879억 | $826억 | $844억 | $916억 | $1060억 | $1090억 | $1070억 | $1170억 | $1370억 | |
| 부채 | |||||||||||
| 매입채무 | $28.1억 | $31억 | $33.2억 | $37.4억 | $43.3억 | $46.1억 | $42.6억 | $39.2억 | $40.8억 | $44억 | |
| 미지급비용 | $103억 | $104억 | $102억 | $125억 | $122억 | $139억 | $142억 | $158억 | $157억 | $8500만 | |
| 단기차입금 | $5.68억 | $30.6억 | $53.1억 | $36.1억 | $64.3억 | $24.1억 | $19.5억 | $13.7억 | $26.5억 | $28.8억 | |
| 미지급세금 | $22.4억 | $7.08억 | $19.7억 | $7.36억 | $15.8억 | $12.2억 | $19.9억 | $26.5억 | $39.1억 | $0 | |
| 기타 유동부채 | $0 | $0 | $0 | $0 | $7.95억 | -$3.04억 | -$2.81억 | -$2.85억 | -$2.82억 | $141억 | |
| 유동부채 | $172억 | $186억 | $222억 | $222억 | $273억 | $239억 | $242억 | $257억 | $284억 | $283억 | |
| 장기차입금 | $243억 | $214억 | $198억 | $227억 | $254억 | $307억 | $287억 | $337억 | $345억 | $468억 | |
| 리스부채(비유동) | $0 | $0 | $0 | $7.68억 | $13.4억 | $12.3억 | $10.1억 | $9.28억 | $8.77억 | $9.01억 | |
| 이연법인세부채 | $50.8억 | $22.2억 | $17억 | $14.7억 | $10.1억 | $34.4억 | $18억 | $8.71억 | $13.9억 | $14.4억 | |
| 기타 비유동부채 | $85.1억 | $111억 | $120억 | $112억 | $112억 | $82.1억 | $73.1억 | $78.6억 | $55.9억 | $67.9억 | |
| 비유동부채 | $379억 | $347억 | $335억 | $362억 | $389억 | $436억 | $389억 | $433억 | $423억 | $559억 | |
| 부채총계 | $551억 | $533억 | $558억 | $584억 | $662억 | $674억 | $631억 | $690억 | $707억 | $842억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | $17.9억 | |
| 이익잉여금 | $441억 | $414억 | $426억 | $466억 | $474억 | $537억 | $611억 | $539억 | $631억 | $731억 | |
| 기타포괄손익누계액 | -$52.3억 | -$49.1억 | -$55.5억 | -$61.9억 | -$66.3억 | -$44.3억 | -$47.7억 | -$51.6억 | -$49.5억 | -$42.9억 | |
| 주주지분 | $401억 | $343억 | $267억 | $259억 | $253억 | $382억 | $460억 | $376억 | $463억 | $526억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $248억 | $244억 | $251억 | $274억 | $334억 | $346억 | $320억 | $363억 | $383억 | $505억 | |
| 순차입금(차입금 - 현금) | $183억 | $183억 | $171억 | $177억 | $254억 | $265억 | $193억 | $294억 | $250억 | $360억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
데이터 기준일 2026-11-01